Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea

Fig. 1

Consort diagram for hormone receptor-positive metastatic breast cancer. Of the total 2611 patients with MBC, confirmed premenopausal patients represented 39% (N = 1019). Ultimately, the review identified 272 premenopausal patients with HR-positive, HER2-negative MBC

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us